177Lu-B5-IgG4

N/A

Report date: 2025/09/22 17:35:17

Base Information

Drug Name177Lu-B5-IgG4

Drug Alias Name177-Lu-B5-IgG4

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Nuclides > Lutetium > 177Lu +[5]

Mechanisms of ActionSingle-photon emission-computed tomography enhancers

TargetsFibronectin

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesAffiliated Hospital of Jiangnan University

China Registration ClassN/A

Develop Information

Active CompaniesAffiliated Hospital of Jiangnan University

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A